133 related articles for article (PubMed ID: 20499665)
1. [Therapeutic recommendations for year 2010: antiviral treatment of chronic HBV infection].
Juszczyk J; Boroń-Kaczmarska A; Cianciara J; Flisiak R; Gładysz A; Halota W; Kryczka W; Małkowski P; Pawłowska M; Simon K;
Przegl Epidemiol; 2010; 64(1):81-2. PubMed ID: 20499665
[No Abstract] [Full Text] [Related]
2. [Polish Experts Group on HBV. Therapeutic recommendations on 2008 year (antiretroviral treatment of chronic hepatitis B)].
Juszczyk J; Boroń-Kaczmarska A; Cianciara J; Flisiak R; Gładysz A; Halota W; Kryczka W; Małkowski P; Pawłowska M; Simon K
Przegl Epidemiol; 2008; 62(2):379-81. PubMed ID: 18807484
[No Abstract] [Full Text] [Related]
3. [Treatment recommendations of chronic hepatitis B. Did the world escape us?].
Flisiak R; Jaroszewicz J
Przegl Epidemiol; 2008; 62(1):133-8. PubMed ID: 18536235
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic recommendations for 2013: antiviral treatment for chronic hepatitis B.
Juszczyk J; Boroń-Kaczmarska A; Cianciara J; Flisiak R; Gładysz A; Halota W; Kryczka W; Małkowski P; Pawłowska M; Simon K;
Przegl Epidemiol; 2013; 67(2):287-95, 383-91. PubMed ID: 24040735
[No Abstract] [Full Text] [Related]
5. Non-interventional study AI463-12 of real-world chronic HBV infection management--baseline characteristics and treatment patterns of Polish patients kohort.
Simon K; Błudzin W; Dziambor A; Goryszewski D; Postawa-Kłosińska B; Sieklucki J; Kolasa K; Lescrauwaet B
Przegl Epidemiol; 2013; 67(4):617-21, 709-12. PubMed ID: 24741906
[TBL] [Abstract][Full Text] [Related]
6. Additive antiviral effects of lamivudine and alpha-interferon in chronic hepatitis B infection.
Mutimer D; Dowling D; Cane P; Ratcliffe D; Tang H; O'Donnell K; Shaw J; Elias E; Pillay D
Antivir Ther; 2000 Dec; 5(4):273-7. PubMed ID: 11142622
[TBL] [Abstract][Full Text] [Related]
7. [A case report of treatment with pegylated interferon alpha for lamivudine-resistant chronic hepatitis B virus infection].
Hur WH; Woo HY; Jeong SW; You CR; Bae SH; Choi JY; Yoon SK
Korean J Hepatol; 2008 Dec; 14(4):513-8. PubMed ID: 19119246
[TBL] [Abstract][Full Text] [Related]
8. Lamivudine treatment for children with interferon refractory chronic hepatitis B.
Koçak N; Saltik IN; Ozen H; Yüce ; Gürakan F
Hepatology; 2000 Feb; 31(2):545. PubMed ID: 10691379
[No Abstract] [Full Text] [Related]
9. [Investigation of oxidative stress and antioxidant defense in patients with hepatitis B virus infection and the effect of interferon-alpha plus lamivudine combination therapy on oxidative stress].
Acar A; Görenek L; Aydin A; Eyigün CP; Eken A; Sayal A; Pahsa A
Mikrobiyol Bul; 2009 Jul; 43(3):411-23. PubMed ID: 19795616
[TBL] [Abstract][Full Text] [Related]
10. [Preliminary results of interferon alpha-2a and lamivudine combination therapy regimen in children with chronic hepatitis B].
Aşik Akman S; Cokçeken Okçu S; Anil OH; Köse S; Bakiler AR
Mikrobiyol Bul; 2006; 40(1-2):47-53. PubMed ID: 16775956
[TBL] [Abstract][Full Text] [Related]
11. [Effects of antiviral agents on intrahepatic ccc DNA in HBeAg-positive chronic hepatitis B patients].
Lu HY; Zhuang LW; Yu YY; Si CW; Li J
Zhonghua Gan Zang Bing Za Zhi; 2008 Mar; 16(3):198-202. PubMed ID: 18364079
[TBL] [Abstract][Full Text] [Related]
12. Antiviral therapy for chronic hepatitis B and C. Which patients are likely to benefit from which agents?
Gordon SC
Postgrad Med; 2000 Feb; 107(2):135-8, 141-4. PubMed ID: 10689413
[TBL] [Abstract][Full Text] [Related]
13. Relapse after treatment with peginterferon alpha-2b alone or in combination with lamivudine in HBeAg positive chronic hepatitis B.
Flink HJ; Buster EH; Merican I; Nevens F; Kitis G; Cianciara J; de Vries RA; Hansen BE; Schalm SW; Janssen HL
Gut; 2007 Oct; 56(10):1485-6. PubMed ID: 17872587
[No Abstract] [Full Text] [Related]
14. Antiviral therapy for hepatitis B infection during pregnancy and breastfeeding.
Giles M; Visvanathan K; Sasadeusz J
Antivir Ther; 2011; 16(5):621-8. PubMed ID: 21817183
[TBL] [Abstract][Full Text] [Related]
15. Peginterferon and lamivudine for hepatitis B.
Assy NN; Hussein O
N Engl J Med; 2004 Dec; 351(27):2879; author reply 2879. PubMed ID: 15625344
[No Abstract] [Full Text] [Related]
16. [Chronic hepatitis B virus infection].
Trifan A; Stanciu C
Rev Med Chir Soc Med Nat Iasi; 2003; 107(1):19-27. PubMed ID: 14755965
[TBL] [Abstract][Full Text] [Related]
17. [Antiviral treatment of HBeAg positive chronic hepatitis B].
Wang GQ
Zhonghua Gan Zang Bing Za Zhi; 2005 Jul; 13(7):540. PubMed ID: 16042897
[No Abstract] [Full Text] [Related]
18. Treatment of HBeAg-positive hepatitis B with peginterferon and lamivudine.
Song K; Rajvanshi P
N Engl J Med; 2005 Oct; 353(15):1630-1; author reply 1630-1. PubMed ID: 16221792
[No Abstract] [Full Text] [Related]
19. Comparison of antiviral effect of lamivudine with interferon-alpha2a versus -alpha2b in children with chronic hepatitis B infection.
Ozgenc F; Dikici B; Targan S; Doganci T; Akman S; Aydogdu S; Yagci RV
Antivir Ther; 2004 Feb; 9(1):23-6. PubMed ID: 15040533
[TBL] [Abstract][Full Text] [Related]
20. Pegylated interferon Alfa-2b monotherapy and pegylated interferon Alfa-2b plus lamivudine combination therapy for patients with hepatitis B virus E antigen-negative chronic hepatitis B.
Kaymakoglu S; Oguz D; Gur G; Gurel S; Tankurt E; Ersöz G; Ozenirler S; Kalayci C; Poturoglu S; Cakaloglu Y; Okten A
Antimicrob Agents Chemother; 2007 Aug; 51(8):3020-2. PubMed ID: 17517832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
